Related Experiment Video
Updated: Aug 16, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
[Meningeal carcinomatosis]
1Arhus Universitetshospital, Arhus Sygehus, Onkologisk Afdeling. sofiasulim@dadlnet.dk
Abstract:
Meningeal carcinomatosis (MC) occurs in 5-8% of cancer patients. In the majority of cases, MC appears in patients with advanced disease. The increase in incidence is probably caused by improved survival due to improvements in systemic therapy and an increased awareness of MC among clinicians. Diagnosis is based on CSF cytology and neuroimaging. MC is a devastating condition that is associated with a poor prognosis, with a median survival time of 4-11 weeks. The treatment is in most cases palliative and involves radiotherapy and/or chemotherapy.
Related Concept Videos
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Viral Meningitis
Cerebral Edema ll: Pathophysiology
